Oral Administration of Protease-Soluble Chicken Type II Collagen Ameliorates Anterior Cruciate Ligament Transection–Induced Osteoarthritis in Rats
Nutrients · 2023
DOI: 10.3390/nu15163589 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von Nan-Fu Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurosurgery, Department of Surgery, Kaohsiung Armed Forces General Hospital, Kaohsiung 80284, Taiwan. Hauptthemen laut MEDLINE: Peptide Hydrolases, Osteoarthritis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taiyen Biotech Co., Ltd., Taiwan., Taiyen Biotech Co., Ltd., Taiwan.
Abstract (Originalsprache)
This study investigated whether oral supplementation with protease-soluble chicken type II collagen (PSCC-II) mitigates the progression of anterior cruciate ligament transection (ACLT)–induced osteoarthritis (OA) in rats. Eight-week-old male Wistar rats were randomly assigned to the following groups: control, sham, ACLT, group A (ACLT + pepsin-soluble collagen type II collagen (C-II) with type I collagen), group B (ACLT + Amano M–soluble C-II with type I collagen), group C (ACLT + high-dose Amano M–soluble C-II with type I collagen), and group D (ACLT + unproteolyzed C-II). Various methods were employed to analyze the knee joint: nociceptive tests, microcomputed tomography, histopathology, and immunohistochemistry. Rats treated with any form of C-II had significant reductions in pain sensitivity and cartilage degradation. Groups that received PSCC-II treatment effectively mitigated the ACLT-induced effects of OA concerning cancellous bone volume, trabecular number, and trabecular separation compared with the ACLT alone group. Furthermore, PSCC-II and unproteolyzed C-II suppressed ACLT-induced effects, such as the downregulation of C-II and upregulation of matrix metalloproteinase-13, tumor necrosis factor-α, and interleukin-1β. These results indicate that PSCC-II treatment retains the protective effects of traditional undenatured C-II and provide superior benefits for OA management. These benefits encompass pain relief, anti-inflammatory effects, and the protection of cartilage and cancellous bone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Neurosurgery, Department of Surgery, Kaohsiung Armed Forces General Hospital, Kaohsiung 80284, Taiwan.
- Institute of Medical Science and Technology, National Sun Yat-sen University, Kaohsiung 80424, Taiwan.
- Department of Sports Medicine, China Medical University, Taichung 40402, Taiwan.
- Department of Orthopedics, Kaohsiung Veterans General Hospital, Kaohsiung 81362, Taiwan.
- Department of Marine Biotechnology and Resources, National Sun Yat-sen University, Kaohsiung 80424, Taiwan.
- R&D Department, Taiyen Biotech Co., Ltd., Tainan 70263, Taiwan.
ORCID-Profile: Zhi-Kang Yao, Zhi-Hong Wen
Förderung
- Taiyen Biotech Co., Ltd., Taiwan.
- Taiyen Biotech Co., Ltd., Taiwan
Zitieren
APA
Chen, N. F., Lin, Y. Y., Yao, Z. K., Tseng, C. C., Liu, Y. W., Hung, Y. P., Jean, Y. H., & Wen, Z. H. (2023). Oral Administration of Protease-Soluble Chicken Type II Collagen Ameliorates Anterior Cruciate Ligament Transection–Induced Osteoarthritis in Rats. Nutrients. https://doi.org/10.3390/nu15163589
Vancouver
Chen NF, Lin YY, Yao ZK, Tseng CC, Liu YW, Hung YP, et al. Oral Administration of Protease-Soluble Chicken Type II Collagen Ameliorates Anterior Cruciate Ligament Transection–Induced Osteoarthritis in Rats. Nutrients. 2023. doi:10.3390/nu15163589
BibTeX
@article{Chen2023,
author = {Chen, Nan-Fu and Lin, Yen-You and Yao, Zhi-Kang and Tseng, Chung-Chih and Liu, Yu-Wei and Hung, Ya-Ping and Jean, Yen-Hsuan and Wen, Zhi-Hong},
title = {Oral Administration of Protease-Soluble Chicken Type II Collagen Ameliorates Anterior Cruciate Ligament Transection–Induced Osteoarthritis in Rats},
journal = {Nutrients},
year = {2023},
doi = {10.3390/nu15163589}
}
EUVIMED